Summary
- Minority ethnic patients with heart failure are more than a third more likely to die than white patients
- Study analyzed data from over 16,700 people from 12 clinical trials
- Beta blockers reduced deaths in white patients but results were inconclusive for minority ethnic patients
- Under-representation of minority ethnic patients in clinical studies highlighted
